|
Index of reports
> All Cases (95)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Clolar (Clofarabine) all cases. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 95 Next >>
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 121.9 kg (268.2 pounds)
Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epinephrine
Dosage: 4 df, unk
Indication: Cardiac Arrest
Start date: 2012-07-14
End date: 2012-07-14
Cyclophosphamide
Dosage: daily for 5 days
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Oncaspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Epinephrine
Dosage: unk
Start date: 2012-07-14
End date: 2012-07-14
Clolar
Dosage: 74.4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Vincristine Sulfate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: male, weighing 115.0 kg (253.0 pounds)
Reactions: Dyspnoea, Pneumonia, Haemoptysis, Rales, Musculoskeletal Pain, Hypotension, Pyrexia, Atrioventricular Block Second Degree, Lung Consolidation, Pulmonary Haemorrhage, Chest Pain, Tachypnoea, Pleural Effusion, Cough
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Busulfan
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-04
End date: 2012-08-08
Clolar
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-03
End date: 2012-08-08
Other drugs received by patient: Vancomycin; Zosyn; Micafungin; Voriconazole; Tacrolimus; Oxycodone HCL; Antibiotics; Methotrexate; Azithromycin; Neupogen; Coreg
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female
Reactions: Pyrexia, Pupils Unequal, Cerebral Ischaemia, Pleural Effusion, Brain Oedema, Intracranial Pressure Increased, Staphylococcal Bacteraemia, Pupil Fixed, Blood Pressure Systolic Decreased, Pupillary Reflex Impaired, Cerebral Artery Stenosis, Brain Stem Haemorrhage, Brain Herniation, Hyperreflexia, Ascites, Convulsion, Venoocclusive Disease, Bacteraemia, Respiratory Failure, Meningitis Bacterial, Mental Disorder, Acute Myeloid Leukaemia Recurrent
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-12
Clolar
Dosage: 52 mg/m2, dose level 3
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-07-13
End date: 2012-07-17
Possible Clolar side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: 61 year old male
Reactions: Dysstasia, Fatigue, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Busulfan
Dosage: 254/332 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
End date: 2012-07-01
Clolar
Dosage: 83 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-27
End date: 2012-07-01
Other drugs received by patient: Allegra; Omeprazole; Vfend; Megace; Prograf; Cyclosporine; Valaciclovir; Cell Cept; Loperamide; Ursodiol; Vancomycin; Cefpodoxime Proxetil; Colecalciferol; Humalog; Magnesium Sulfate; Prednisone TAB
Possible Clolar side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa
Possible Clolar side effects in female
Reported by a physician from Australia on 2012-07-19
Patient: female
Reactions: Atrial Fibrillation, Febrile Neutropenia, Constipation, Delusion, Haemoglobin Decreased, Fatigue, Myocardial Infarction, Hallucination, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2010-10-25
End date: 2010-10-29
Clolar
Dosage: unk
Start date: 2010-11-29
End date: 2010-12-03
Other drugs received by patient: Metformin Hydrochloride
Possible Clolar side effects in 63 year old female
Reported by a consumer/non-health professional from United States on 2012-07-11
Patient: 63 year old female, weighing 125.2 kg (275.4 pounds)
Reactions: Urinary Tract Infection, Enterococcus Test Positive, Klebsiella Test Positive, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 30 mg/m2, qd, on days -6 through day -2
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-31
End date: 2012-04-04
Thymoglobulin
Dosage: 1.5 mg/kg, qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-26
End date: 2012-03-30
Other drugs received by patient: Atovaquone; Mycophenolate Mofetil; Clonazepam; Nystatin; Heparin; Total Lymphoid Irradiation; Miconazole; Magnesium Sulfate; Filgrastim; Levetiracetam; Lacosamide; Senna-Mint WAF; Fluconazole; Cyclosporine; Valganciclovir; Ondansetron; Labetalol HCL; Vitamin D; Acetaminophen; Acetaminophen
Possible Clolar side effects in female
Reported by a pharmacist from United States on 2012-07-10
Patient: female
Reactions: Ejection Fraction Decreased
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in 63 year old female
Reported by a physician from United States on 2012-06-28
Patient: 63 year old female
Reactions: Urinary Tract Infection, Enterococcus Test Positive, Klebsiella Test Positive, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thymoglobulin
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-01-01
Clolar
Dosage: 30 mg/m2, qd, on days -6 through day -2
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-31
End date: 2012-04-04
Other drugs received by patient: Filgrastim; Lacosamide; Acetaminophen; Levetiracetam; Nystatin; Cyclosporine; Heparin; Vitamin D; Valganciclovir; Atovaquone; Clonazepam; Magnesium Sulfate; Fluconazole; Labetalol HCL; Acetaminophen; Ondansetron (Zofran); Miconazole; Senna-Mint WAF; Total Lymphoid Irradiation; Mycophenolate Mofetil
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28
Patient: male, weighing 74.8 kg (164.6 pounds)
Reactions: Enterovesical Fistula, Oedema Peripheral, Febrile Neutropenia, Abscess
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 3820 mg, qd for induction treatment, for 5 days
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-16
End date: 2012-03-20
Cytarabine
Dosage: 3600 mg, qd, for 4 days
Start date: 2012-04-28
End date: 2012-05-01
Neupogen
Dosage: 300 mcg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-15
End date: 2012-04-04
Clolar
Dosage: 57.3 mg, qd, for 5 days
Start date: 2012-03-16
End date: 2012-03-20
Neupogen
Dosage: 300 mcg, qd
Start date: 2012-04-28
End date: 2012-05-01
Clolar
Dosage: 46 mg, qd for consolidation treatment
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-28
Other drugs received by patient: Nicotine; Docusate; Lorazepam; Hydrocodone Bitartrate and Acetaminophen; Ondansetron (Zofran); Omeprazole; Lorazepam; Zolpidem; Acyclovir; Senna-Mint WAF; Oxycodone HCL; Levaquin; Voriconazole
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15
Patient: male, weighing 83.4 kg (183.5 pounds)
Reactions: Hepatic Failure
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Acyclovir; Fluconazole; Ceftazidime; Filgrastim; Voriconazole
Possible Clolar side effects in 11 year old male
Reported by a physician from Argentina on 2012-06-14
Patient: 11 year old male
Reactions: Multi-Organ Failure, Cardiac Failure, Hypotension, Sepsis, Electrolyte Imbalance
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: unk
Cyclophosphamide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: unk
Etoposide
Dosage: unk
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: male
Reactions: Sepsis, Febrile Neutropenia, Bradycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in 66 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: 66 year old male
Reactions: Febrile Neutropenia, Bradycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in male
Reported by a physician from United States on 2012-06-05
Patient: male
Reactions: Enterovesical Fistula, Oedema Peripheral, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Clolar
Dosage: 46 mg, qd for consolidation treatment
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-28
Clolar
Dosage: for induction treatment
Start date: 2012-03-16
End date: 2012-03-20
Neupogen
Dosage: unk
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Oxycodone Hydrochloride; Docusate; Levaquin; Acyclovir; Hydrocodone Bitartrate and Acetaminophen; Lorazepam; Voriconazole; Nicotine; Omeprazole; Lorazepam; Zolpidem; Senna-Mint WAF; Ondansetron
Possible Clolar side effects in male
Reported by a physician from United States on 2012-06-04
Patient: male, weighing 83.4 kg (183.5 pounds)
Reactions: Hyperbilirubinaemia, Hypoalbuminaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Voriconazole; Acyclovir; Ceftazidime; Filgrastim; Fluconazole
Possible Clolar side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: 66 year old female
Reactions: Dyspnoea, Pericardial Effusion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thymoglobulin
Indication: non-Hodgkin's Lymphoma
Clolar
Dosage: 30 mg/m2, qdx5
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-01-14
End date: 2012-01-18
Clolar
Indication: non-Hodgkin's Lymphoma
Thymoglobulin
Dosage: unk
Indication: Bone Marrow Conditioning Regimen
Other drugs received by patient: Dapsone; Acyclovir; Cholestyramine; Cyclosporine; Folic Acid; Lidocaine; Prilocaine Hydrochloride; Doxepin; Omeprazole; Sertraline Hydrochloride; Oxycodone HCL; Lorazepam
Possible Clolar side effects in 12 year old female
Reported by a physician from Argentina on 2012-05-25
Patient: 12 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Possible Clolar side effects in 64 year old male
Reported by a consumer/non-health professional from United States on 2012-05-24
Patient: 64 year old male
Reactions: Abdominal Pain, Post Transplant Lymphoproliferative Disorder, Nausea, Diarrhoea, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Thymoglobulin
Indication: Stem Cell Transplant
Rituximab
Dosage: protocol 09-346
Indication: Post Transplant Lymphoproliferative Disorder
Clolar
Dosage: 30 mg/m2, qd day -6 through -2
Indication: Stem Cell Transplant
Start date: 2012-02-04
End date: 2012-02-08
Clolar
Indication: Multiple Myeloma
Thymoglobulin
Dosage: unk
Indication: Multiple Myeloma
Bortezomib
Dosage: protocol 09-346
Indication: Post Transplant Lymphoproliferative Disorder
Rituximab
Dosage: protocol 09-346 day 11
Bortezomib
Dosage: protocol 09-346
Bortezomib
Dosage: protocol 09-346, day 11
Rituximab
Dosage: protocol 09-346
Other drugs received by patient: Acyclovir; Folic Acid; Multi-Vitamin; Albuterol; Cyclosporine; Pentamidine Isethionate; Oxycodone HCL; Prednisone; Amlodipine Besylate; Carvedilol; Lorazepam; Ondansetron; Prochlorperazine Maleate; Omeprazole; Colecalciferol
Possible Clolar side effects in male
Reported by a physician from Argentina on 2012-05-23
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Device Related Sepsis, Vomiting, Rash Erythematous, Febrile Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: 150 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient: male
Reactions: Hyperbilirubinaemia, Hypoalbuminaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Filgrastim; Acyclovir; Voriconazole; Fluconazole; Ceftazidime
Possible Clolar side effects in 7 year old female
Reported by a physician from Argentina on 2012-05-15
Patient: 7 year old female
Reactions: Acute Lymphocytic Leukaemia, Pigmentation Disorder, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Dosage: 40 mg/m2, qdx5
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Etoposide
Dosage: 150 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Cyclophosphamide
Dosage: 440 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Clolar
Dosage: 40 mg/m2, qdx5
Indication: Acute Lymphocytic Leukaemia Recurrent
Etoposide
Dosage: 150 mg/m2, qdx5
Possible Clolar side effects in female
Reported by a pharmacist from United States on 2012-05-15
Patient: female
Reactions: Skin Reaction
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in female
Reported by a consumer/non-health professional from United States on 2012-04-25
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in male
Reported by a physician from United States on 2012-04-24
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Cardio-Respiratory Arrest, Mouth Haemorrhage, Unresponsive To Stimuli, Febrile Neutropenia, Pleural Effusion, Pancytopenia, Pneumonitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clolar
Possible Clolar side effects in female
Reported by a physician from United States on 2012-04-24
Patient: female, weighing 41.7 kg (91.7 pounds)
Reactions: Contusion, Skin Exfoliation, Pyrexia, Haematemesis, Oral Candidiasis, Skin Discolouration, Epistaxis, Blood Pressure Increased, Swelling Face, Stomatitis, Vomiting, Pain in Extremity, Nausea, Acute Lymphocytic Leukaemia, Renal Failure, Diarrhoea
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clolar
Other drugs received by patient: Promethazine; Vinorelbine; Zosyn; Linezolid; Amphojel; Meropenem; Nystatin; Norvasc; Octreotide Acetate; Dexamethasone; Vinorelbine; Caphosol; Vinorelbine; Pepcid; Zoloft; Bactrim; Caspofungin Acetate; Thiotepa; RED Blood Cells, Concentrated; Platelets; Allopurinol; Acyclovir; Solutions FOR Parenteral Nutrition; Oxycodone HCL; Neupogen; Ondansetron; Lorazepam; Zithromax; Vfend; Vancomycin; Octreotide Acetate; Topotecan; Cefepime; Imodium; Dexamethasone; D5 1 / 2 NS + KCL 20 MEQ / L; Imodium
Possible Clolar side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-17
Patient: male, weighing 116.6 kg (256.5 pounds)
Reactions: Renal Failure, Pneumonia, Neutropenic Colitis, Neutropenic Sepsis, Hypotension, Pleural Effusion, Mental Status Changes, Staphylococcal Bacteraemia, Pulseless Electrical Activity
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Clolar
Dosage: 94 mg, once
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-29
End date: 2012-04-02
Busulfan
Dosage: 249 mg, once
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-03-31
Clolar
Indication: Bone Marrow Conditioning Regimen
Busulfan
Dosage: 390 mg, once
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-04-01
End date: 2012-04-02
Page 1 Next >>
|
